載入...
Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.
The Ebola virus is transmitted by direct contact with bodily fluids of infected individuals, eliciting death rates as high as 90% among infected humans. Currently, replication defective adenovirus-based Ebola vaccine is being studied in a phase I clinical trial. Another Ebola vaccine, based on an at...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science (PLoS)
2009-01-01
|
| 叢編: | PLoS ONE |
| 在線閱讀: | http://europepmc.org/articles/PMC2669164?pdf=render |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|